Skip to main content
OpenTrials
Completed

NCT Number: NCT03307733

Walking in Pregnancy (WiP) - a Social Networking Physical Activity Intervention for Pregnant Obese Women

A physical activity feasibility randomised control trial for pregnant, obese women.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

Overweight (defined as BMI ≥25kg/m2) and obesity (defined as BMI ≥30kg/m2) during pregnancy is becoming more common. Approximately 25-30% of women of childbearing age are obese and around 50% are overweight at the time of conception. Women who are either overweight or obese have a much higher risk of adverse pregnancy outcomes. For example, they are more likely to develop gestational diabetes, pregnancy-induced hypertension, pre-eclampsia, Caesarean section and other complications. Recent research suggests that overweight and obese pregnant women are less active than normal weight ( BMI≤ 25kg/m2) pregnant women and also that the level of physical activity decreases throughout pregnancy. The evidence also suggests that maintaining a good level of physical activity can reduce the risks of adverse pregnancy outcomes. A large study which looked at the most preferred types of physical activity identified that walking and swimming were the most preferred types of physical activity by pregnant women. Although there is an association between walking at a brisk pace and a reduced risk of gestational diabetes, there is no definitive conclusion on the effectiveness of walking interventions. The investigators are proposing this feasibility study in order to find out whether a walking intervention can be implemented during pregnancy in the obese population to reduce adverse pregnancy health outcomes. The current study will investigate whether a Fitibit Pedometer and a Social networking Site (Facebook) can be used to encourage pregnant, obese women to increase and maintain activity during pregnancy. The feasibility study will test the recruitment strategy, acceptability of the intervention design, randomisation acceptability, and timing of the intervention. Participants from both the control and the intervention will be purposefully selected to take part in focus group following the intervention in order to give feedback on the study. The investigators will be working with an Obstetrics & Gynaecology consultant at Jessop Wing, Hallamshire Hospital to help with the recruitment process and provide clinical advice. Women who are obese (BMI>30kg/m2) in their early pregnancy (12-14 weeks) will be recruited. Participants that consent to take part in the study will be given a Fitbit pedometer and enrolled in a closed Facebook group. Each participant will wear a Fitbit for a week in order to measure their baseline physical activity level. Thereafter, the participants in the intervention will be asked to gradually increase their physical activity level (they will be given a weekly step target)for 4 weeks in total. The Facebook component of the intervention will contain motivational and educational posts and rewarding messages about their progress. The control group will be asked to wear a Fitbit for 5 weeks and do their usual activities in total with a covered screen so as to not see the step count

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pregnant 11-14 weeks gestation
  • BMI >30kg/m2
  • No known risks or complications
  • Able to walk

Exclusion criteria

  • High risk of miscarriage

Treatment and study plan

walking and behavour change techniques

Behavioral

a Fitbit pedometer with individualised step targets and partaking in a closed Facebook group

Primary outcomes

  1. Recruitment

    Time frame: 5 weeks

    Recruitment rate will be calculated by simple descriptive statistics. (number of participants approached vs. number of participants that agree to take part)

  2. Compliance

    Time frame: 5 weeks

    Compliance to the study procedures will be calculated by simple descriptive. statistics

  3. Attrition

    Time frame: 5 weeks

    Drop out rate will be calculated by simple descriptive statistics.

  4. Adherence rates

    Time frame: 5 weeks

    Adherence to Fitbit will be measured daily.

Secondary outcomes

  1. Gestational Weight Gain

    Time frame: 5 weeks

    Women are recruited at 11-14 weeks gestation and after 5 weeks when they are at 20 weeks gestation the final assessments will be collected. Weight is measured in kilograms.

  2. gestational diabetes status

    Time frame: 26 weeks

    Outcome of the gestational diabetes mellitus test at 26 weeks gestation.

  3. Pregnancy and Birth outcomes

    Time frame: 9 months

    Preeclampsia ( Percentage figure of patients who developed preeclampsia during birth will be calculated from clinical notes).

  4. C-section

    Time frame: 9 months

    Mode of Delivery ( Number of participants from each group who have a C-section will be calculated)

  5. Birth weight

    Time frame: At delivery ( 9 months roughly)

    Weight of the baby at birth. This data will be collected from clinical notes.

  6. Apgar score

    Time frame: At delivery ( 9 months roughly)

    5 minute Apgar Score. Score data will be collected from clinical notes.

Sponsors and collaborators

Lead sponsor

Sheffield Hallam University

Other

Registry information

Acronym: WiP

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Oct 12, 2017
Registry last updated
Oct 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.